Abstract
We report the case of a 47-year-old woman with a history of mitral valve replacement with a mechanical prosthesis who was admitted to the hospital with a 3-month history of progressive exertional dyspnoea and was diagnosed as suffering from prosthetic valve thrombosis. Two consecutive courses of streptokinase were given as an intravenous infusion over 90 min at a dose of 1,500,000 IU each. Twenty minutes after the start of the second infusion (3 h and 20 min after the first one) she developed chills, fever, tachycardia and hypotension; symptomatic treatment was given and the infusion was completed. Two days later jaundice and choluria appeared with laboratory findings of hepatic cytolysis and cholestasis and renal insufficiency. The results of extensive microbiological and immunological investigations were not revealing. All the laboratory values spontaneously returned to baseline levels over the next 4 weeks. These abnormalities were attributed to an allergic reaction to streptokinase, although the exact pathogenic mechanisms involved are not known. We believe that further studies to elucidate the mechanisms involved in the production of these effects are warranted in view of their potential clinical severity.
Similar content being viewed by others
References
Bednarczyk EM, Sherlock SC, Farah MG, Green JA. Anaphylactic reaction to streptokinase with first exposure: case report and review of the literature. DICP 1989;23:869–72.
McGrath KG, Patterson R. Anaphylactic reactivity to streptokinase. JAMA 1984;252:1314–7.
Maclennan AC, Ahmad N, Lawrence JR. Activities of aminotransferases after treatment with streptokinase for acute myocardial infarction. BMJ 1990;301:321–2.
Marder VJ, Sherry S. Thrombolytic therapy: current status (second of two parts). N Engl J Med 1988;318:1585–95.
Besse P, Ledain L, Ohayan J, Colle JP, Roudaut MF, Roudaut R. Thromboses aigües de prothèses valvulaires a disque: traitment fibrinolytique. Haemostasis 1986;16(Suppl 4):94–105.
Ortuño J, Fontcuberta J, Pons G, Montserrat I, Cladellas M, Llobet JM, Grau E. Successful treatment of prosthetic heart-valve thrombosis with high short-term doses of streptokinase. Lancet 1988;2:626.
Gruppo Italiano per lo Studio della Streptochinasi nell Infarto miocardio (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1:397–402.
Caron J, Libersa C. Drugs affecting blood clotting, fibrinolysis and hemostasis. In: Dukes MNG, editor. Meyler's side-effects of drugs. 12th ed. Amsterdam: Elsevier, 1992:733–75.
Sheffer AI. Anaphylaxis. J Allergy Clin Immunol 1985;75:227–33.
McGrath KG, Zeffren B, Alexander J, Kaplan K, Patterson R. Allergic reactions to streptokinase consistent with anaphylactic or antigen-antibody complex-mediated damage. J Allergy Clin Inmunol 1985;76:453–57.
Noel J, Rosenbaun LH, Gagadharan V, Stewart J, Galens G. Serum sickness-like illness and leukocytoclastic vasculitis following intracoronary arterial streptokinase. Am Heart J 1987;113:395–7.
Argent N, Adams PC. Proteinuria and thrombolytic agents. Lancet 1990;335:106.
Payne ST, Hosker HSR, Allen MB, Bradbury H, Page RL. Transient impairment of renal function after streptokinase therapy. Lancet 1989;2:1398.
Sallen MK, Efrusy ME, Kniaz JL, Wolfson PM. Streptokinase-induced hepatic dysfunction. Am J Gastroenterol 1983;78: 523–4.
Freimark D, Leor R, Hod H, Elian D, Kaplinsky E, Rabinowitz B. Impaired hepatic function tests after thrombolysis for acute myocardial infarction. Am J Cardiol 1985;67:227–33.
Polkey MI. Hepatic dysfunction induced by streptokinase. Am J Gastroenterol 1992;87:1062.
Karch F, Lasagna L. Toward the operational identification of adverse drug reaction. Clin Pharmacol Ther 1977;21:247–54.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Montserrat, I., Altimiras, J., Dominguez, M. et al. Adverse reaction to streptokinase with multiple systemic manifestations. Pharm World Sci 17, 168–171 (1995). https://doi.org/10.1007/BF01879712
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01879712